Scientists from Spain and India Lead an International Project to Develop New Antibiotics Against Gram-Negative Bacteria
ABAC Therapeutics, together with the artificial intelligence (AI) company, Peptris, and the Foundation for Neglected Disease Research (FNDR), with scientific support from Medicines for Malaria Venture